Barclays
OSCR icon

Barclays’s Oscar Health OSCR Stock Holding History

Barclays’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.9M Sell
427,506
-239,238
-36% -$3.37M ﹤0.01% 1834
2025
Q4 		$9.58M Buy
666,744
+269,304
+68% +$4.66M ﹤0.01% 1712
2025
Q3 		$7.52M Buy
397,440
+28,282
+8% +$466K ﹤0.01% 1889
2025
Q2 		$7.91M Buy
369,158
+96,165
+35% +$1.43M ﹤0.01% 1736
2025
Q1 		$3.58M Sell
272,993
-88,069
-24% -$1.31M ﹤0.01% 2180
2024
Q4 		$4.85M Buy
361,062
+35,244
+11% +$567K ﹤0.01% 2201
2024
Q3 		$6.91M Buy
325,818
+223,189
+217% +$4.02M ﹤0.01% 1777
2024
Q2 		$1.62M Sell
102,629
-51,277
-33% -$942K ﹤0.01% 2286
2024
Q1 		$2.29M Sell
153,906
-183,730
-54% -$2.52M ﹤0.01% 2458
2023
Q4 		$3.09M Buy
337,636
+234,358
+227% +$1.62M ﹤0.01% 2538
2023
Q3 		$575K Buy
103,278
+51,268
+99% +$359K ﹤0.01% 2704
2023
Q2 		$419K Sell
52,010
-9,288
-15% -$68.5K ﹤0.01% 2865
2023
Q1 		$401K Sell
61,298
-840
-1% -$3.43K ﹤0.01% 3418
2022
Q4 		$153K Buy
62,138
+57,129
+1,141% +$179K ﹤0.01% 3992
2022
Q3 		$25K Sell
5,009
-28,323
-85% -$165K ﹤0.01% 3994
2022
Q2 		$141K Buy
33,332
+24,536
+279% +$156K ﹤0.01% 3611
2022
Q1 		$88K Buy
+8,796
New +$65.4K ﹤0.01% 3845

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's OSCR Position: Q1 2026 in Review

Barclays reduced its Oscar Health (OSCR) stake by 36% in Q1 2026, selling an estimated $3.37M and leaving 427,506 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Barclays first reported a position in OSCR in Q1 2022 and has held it in 17 quarters since. The position peaked at $9.58M in Q4 2025. 332 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Barclays held 427,506 shares of Oscar Health worth $4.9M as of Q1 2026.
  • Barclays sold 239,238 Oscar Health shares in Q1 2026, an estimated $3.37M.
  • Oscar Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1834 holding.
  • Barclays first reported a position in Oscar Health in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Oscar Health position peaked at $9.58M in Q4 2025.
  • 332 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.